Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors

Código QR

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors

Guardado en:

Detalles Bibliográficos
Autores principales:	Yusuke Suenaga, Christer Einvik, Atsushi Takatori, Yuyan Zhu
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	MYCN neuroblastoma brain tumor hepatocellular carcinoma therapeutic targets Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/c726a50aa68a424490e72067c601ac31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

MYC regulates metabolism through vesicular transfer of glycolytic kinases
por: Alexia Tsakaneli, et al.
Publicado: (2021)

Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti I, et al.
Publicado: (2020)

Neuroblastomas en el niño
por: E,BAUZA, et al.
Publicado: (1950)

Role of Rab GTPases in Hepatocellular Carcinoma
por: Yang CC, et al.
Publicado: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

Occurrence of Esophageal Atresia With Tracheoesophageal Fistula in Siblings From Three-Generation Family Affected by Variable Expressivity MYCN Mutation: A Case Report
por: Magdalena Klaniewska, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo M, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
por: Luo M, et al.
Publicado: (2021)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
por: Li F, et al.
Publicado: (2020)

MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4
por: Xianbao Huang, et al.
Publicado: (2021)

Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Yong Jin, et al.
Publicado: (2021)

Diagnóstico diferencial y cirugía mínimamente invasiva de un tumor suprarrenal de hallazgo antenatal
por: Lemus Marcenaro,Montserrat, et al.
Publicado: (2019)

miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li F, et al.
Publicado: (2018)

Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma
por: Liang J, et al.
Publicado: (2017)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej K, et al.
Publicado: (2021)

Tumores del tórax en niños
por: Pruyas,Tomas, et al.
Publicado: (1976)

Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol
por: Jiang Bo, et al.
Publicado: (2021)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Kexin Xu, et al.
Publicado: (2021)

Hematocele y hemoperitoneo como manifestación inicial de carcinoma hepatocelular: Caso clínico
por: Schiappacasse-Faúndes,Giancarlo, et al.
Publicado: (2021)

Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018)

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao M, et al.
Publicado: (2018)

Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies
por: Jiaxuan Xu, et al.
Publicado: (2021)

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
por: Li T, et al.
Publicado: (2021)

The Role of Exosomes in Viral Hepatitis and Its Associated Liver Diseases
por: Hao Zhou, et al.
Publicado: (2021)

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
por: Masatoshi Kudo
Publicado: (2021)

NTRK1/TrkA Signaling in Neuroblastoma Cells Induces Nuclear Reorganization and Intra-Nuclear Aggregation of Lamin A/C
por: Lukas Funke, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Changjing Huang, et al.
Publicado: (2021)

Neuroblastoma intrarenal mimetizando tumor de Wilms
por: Maria T. Cartaxo Muniz, et al.
Publicado: (2005)

Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies
por: Jacques Zimmer, et al.
Publicado: (2021)

Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Shuai Zhao, et al.
Publicado: (2021)

Potential antitumor activity of novel DODAC/PHO-S liposomes
por: Luna ACL, et al.
Publicado: (2016)

Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma
por: Mei Luo, et al.
Publicado: (2021)

The Hidden Link of Exosomes to Head and Neck Cancer
por: Yong Teng, et al.
Publicado: (2021)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Shohei Mukai, et al.
Publicado: (2021)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Hui-Chuan Sun, et al.
Publicado: (2021)

Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Pierpaolo Biondetti, et al.
Publicado: (2021)

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study
por: Jun-Yi Wu, et al.
Publicado: (2021)

The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria
por: Hiroaki Takaya, et al.
Publicado: (2021)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
por: Ouyang T, et al.
Publicado: (2021)

Association of Tumor Hydroxyindole O-Methyltransferase and Serum 5-Methoxytryptophan with Long-Term Survival of Hepatocellular Carcinoma
por: Bor-Sheng Ko, et al.
Publicado: (2021)